List of works - Tilman Todenhöfer

A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors

scientific article published on 11 May 2012

Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? ⬇️

scientific article published on March 11, 2012

An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer

scientific article published on 10 April 2017

Androgen receptor overexpression in prostate cancer in type 2 diabetes

scientific article published on 5 December 2017

Assessment of a new point-of-care system for detection of prostate specific antigen

scientific article published on 19 January 2016

Circulating fibronectin controls tumor growth

scientific article published on August 2013

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

scientific article published on 09 January 2014

Current status of molecular markers for prognostication and outcome in invasive bladder cancer ⬇️

scientific article published on January 11, 2012

Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience

scientific article published on 6 February 2017

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

scientific article

Endoscopic Inguinofemoral Lymphadenectomy—Extended Follow-up ⬇️

scientific article published on December 26, 2012

Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer

scientific article published on 10 April 2018

High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.

scientific article

Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?

scientific article published on 4 February 2017

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

scientific article

Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer

scientific article

Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer

scientific article

Intracorporeal ileal ureter replacement using laparoscopy and robotics

scientific article

Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?

scientific article

Isolated, disseminated and circulating tumour cells in prostate cancer ⬇️

scientific article published on July 10, 2012

Liquid biopsy: ready to guide therapy in advanced prostate cancer?

scientific article published on 19 July 2016

Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer - 5-year experience in a single-center

scientific article published on 2 June 2011

Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.

scientific article

Optimal use and outcomes of orthotopic neobladder reconstruction in men and women ⬇️

scientific article published on September 1, 2013

Personalized Treatment of Prostate Cancer Based on Inherited Variations of Steroid Pathway–Related Genes ⬇️

scientific article published on January 3, 2012

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria ⬇️

scientific article published on November 22, 2011

Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients

scientific article published on August 1, 2012

Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy

scientific article published on 28 May 2015

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.

scientific article

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study

scientific article published on 13 January 2014

Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma

scientific article

Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.

scientific article published on 11 December 2014

Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.

scientific article

Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure

scientific article

Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible?

scientific article published on 31 December 2014

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma ⬇️

scientific article published on March 21, 2012

Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps

scientific article published in May 2015

Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer

scientific article

Surface CD24 distinguishes between low differentiated and transit‐amplifying cells in the basal layer of human prostate ⬇️

scientific article published on July 8, 2013

Surgical removal of retroperitoneal tumors after chemotherapy treated testicular tumors

scientific article

Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

scientific article published on 2 June 2015

Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies.

scientific article

The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer ⬇️

scientific article published on September 1, 2011

Thymidine kinase and cancer monitoring.

scientific article

Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial

scientific article published on 18 March 2020

Upper urinary tract laparoendoscopic single-site surgery based on a novel cost-effective reusable platform

scientific article published on 25 October 2012

Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer

scientific article published on 14 June 2016

List of works by Tilman Todenhöfer

A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors

Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? ⬇️

An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer

Androgen receptor overexpression in prostate cancer in type 2 diabetes

Assessment of a new point-of-care system for detection of prostate specific antigen

Circulating fibronectin controls tumor growth

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

Current status of molecular markers for prognostication and outcome in invasive bladder cancer ⬇️

Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

Endoscopic Inguinofemoral Lymphadenectomy—Extended Follow-up ⬇️

Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer

High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.

Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer

Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer

Intracorporeal ileal ureter replacement using laparoscopy and robotics

Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?

Isolated, disseminated and circulating tumour cells in prostate cancer ⬇️

Liquid biopsy: ready to guide therapy in advanced prostate cancer?

Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer - 5-year experience in a single-center

Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.

Optimal use and outcomes of orthotopic neobladder reconstruction in men and women ⬇️

Personalized Treatment of Prostate Cancer Based on Inherited Variations of Steroid Pathway–Related Genes ⬇️

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria ⬇️

Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients

Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study

Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma

Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.

Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.

Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure

Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible?

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma ⬇️

Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps

Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer

Surface CD24 distinguishes between low differentiated and transit‐amplifying cells in the basal layer of human prostate ⬇️

Surgical removal of retroperitoneal tumors after chemotherapy treated testicular tumors

Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies.

The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer ⬇️

Thymidine kinase and cancer monitoring.

Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial

Upper urinary tract laparoendoscopic single-site surgery based on a novel cost-effective reusable platform

Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer